Loading
Latest filing published 21 Sept 2026 for Rainmed Medical Ltd. - B, €1,813.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Huo Yunlong (chief executive) discloses dealings in Rainmed Medical Ltd. - B to HKEX. In total, 7 filings cover trades dated from 26 August 2024 to 17 September 2026.
Purchases make up the whole of the open-market record (6 purchases, €16k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 4 purchases and no sales on the market.
Half of the purchases are above €2,630 and half below. As a share of market capitalisation, the median purchase stands at 0.0067%, based on 3 purchases. Clusters matter here: 1 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 21 September 2026, reports an open-market purchase of €1,813 in Rainmed Medical Ltd. - B. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations